Lexpos News

This Medicines Supply Notification supersedes the National Patient Safety Alert issued on 29 July 2025 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Antimicrobial Agents Used in Tuberculosis (TB) Treatment MSN/2025/058 Tier 3 – high impact Date of issue: 23rd October 2025 Following the National Patient Safety Alert issued [...]

The post Medicine Supply Notification: Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.

Pharmacist flexibilities “should be the norm”, Community Pharmacy England has said in a draft response to Government proposals. A Department of Health and Social Care’s (DHSC’s) consultation is proposing enabling community pharmacists to supply a different strength or formulation (which may mean a different quantity) of the same medicine originally prescribed where the prescribed medicine [...]

The post Community Pharmacy England publishes draft response to pharmacist flexibilities consultation appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (23/10/2025) confirmed the following list of price concessions for October 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.85 Bumetanide 1mg tablets 28 £2.95 Buprenorphine 8mg sublingual tablets sugar free 7 £3.85 Clarithromycin 125mg/5ml oral suspension 70 £10.88 Clarithromycin 250mg/5ml oral suspension 70 £19.67 Duloxetine [...]

The post October 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) Drug Alert Number: EL(25)A/45 Date issued: 23 October 2025 Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. [...]

The post MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltf) Date issued: 23 October 2025 Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error. DMRC reference number: DMRC-36849945/DMRC-36701307 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltd) appeared first on Community Pharmacy England.